Open AccessSerum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
Author(s) -
Jingyi Hu,
Hailan Zou,
Yanhua Li,
Dong-Ying Nie,
Chao Chen,
Jin-Han Liu,
Jin Ding,
Zhou Zhang,
Yang Xiao
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001574
Subject(s) - dyslipidemia , medicine , macrovascular disease , type 2 diabetes , diabetes mellitus , coronary artery disease , fgf21 , fgf19 , endocrinology , disease , biomarker , lipid profile , gastroenterology , fibroblast growth factor , biology , receptor , biochemistry